US PATENT SUBCLASS 435 / 343
.~.~.~ Binds a hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)


Current as of: June, 1999
Click HD for Main Headings
Click for All Classes

Internet Version by PATENTEC © 1999      Terms of Use



435 /   HD   CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY

325  DF  ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE {17}
326  DF  .~ Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof {7}
332  DF  .~.~ Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.) {12}
343.~.~.~ Binds a hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell surface antigen, hemoglobin, thrombospondin, glycophorin, etc.) {1}
343.1  DF  .~.~.~.~> Binds a lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage, acute lymphoblastic leukemia cell, B-lymphocytic cell surface antigen, etc.) {1}


DEFINITION

Classification: 435/343

Binds a hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell,

granulocytic cell surface antigen, hemoglobin, thrombospondin, glycophorin, etc.):

(under subclass 332) Subject matter involving an animal cell which produces a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with an integral or isolated part of a hematopoietic cell, or with a substance shed or secreted by a hematopoietic cell.

(1) Note. Hematopoietic cells are considered to be bone marrow stem cells and cells derived from bone marrow stem cells including cells at any stage of differentiation from progenitor cells to mature erythrocytes, granulocytes, lymphocytes, etc., both normal and neoplastic.